These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 20524812)
21. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Jacobson IM; Davis GL; El-Serag H; Negro F; Trépo C Clin Gastroenterol Hepatol; 2010 Nov; 8(11):924-33; quiz e117. PubMed ID: 20713178 [TBL] [Abstract][Full Text] [Related]
22. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421 [TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma and hepatitis C in the United States. El-Serag HB Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579 [TBL] [Abstract][Full Text] [Related]
24. Hepatic siderosis, fibrosis and cirrhosis: the association with hepatocellular carcinoma in high-risk population. Jaskiewicz K; Banach L; Lancaster E Anticancer Res; 1997; 17(5B):3897-9. PubMed ID: 9427800 [TBL] [Abstract][Full Text] [Related]
25. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis]. Schott E; Bergk A; Berg T Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819 [TBL] [Abstract][Full Text] [Related]
26. [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany]. Erhardt A; Theobald I; Petry W; Röhrborn A; Heintges T; Wettstein M; Häussinger D Dtsch Med Wochenschr; 2002 Dec; 127(50):2665-8. PubMed ID: 12481236 [TBL] [Abstract][Full Text] [Related]
27. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330 [TBL] [Abstract][Full Text] [Related]
28. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States. Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547 [TBL] [Abstract][Full Text] [Related]
29. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya. Mwangi J; Gatei DG East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308 [TBL] [Abstract][Full Text] [Related]
31. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma. Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170 [TBL] [Abstract][Full Text] [Related]
32. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078 [TBL] [Abstract][Full Text] [Related]
33. [An analysis of clinical characteristics and risk factors of cirrhosis-related hepatocellular carcinomas in patients with hepatitis C virus infection]. Wu CH; Tian GS; Xu XY; Yu YY; Huang T Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):210-4. PubMed ID: 18364082 [TBL] [Abstract][Full Text] [Related]
34. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C. Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809 [TBL] [Abstract][Full Text] [Related]
35. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323 [TBL] [Abstract][Full Text] [Related]
36. Viral hepatitis and hepatocellular carcinoma. Marrero CR; Marrero JA Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352 [TBL] [Abstract][Full Text] [Related]
37. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763 [TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma in HIV hepatitis C virus. Puoti M; Rossotti R; Garlaschelli A; Bruno R Curr Opin HIV AIDS; 2011 Nov; 6(6):534-8. PubMed ID: 21934618 [TBL] [Abstract][Full Text] [Related]
40. [Association of cirrhosis and hepatocellular carcinoma with porphyria cutanea tarda]. Ishibashi H; Matsunaga T; Dohmen K Nihon Rinsho; 1995 Jun; 53(6):1474-8. PubMed ID: 7616664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]